We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Breast Tomosynthesis Detects More Cancers than Mammography

By HospiMedica International staff writers
Posted on 25 Oct 2018
A team of researchers from the Lund University (Lund, Sweden) and Skåne University Hospital (Scania, Sweden) screened 15,000 women over a period of five years to find that three-dimensional (3D) mammography, or breast tomosynthesis, detects over 30% more cancers than traditional mammography, with most of the detected tumors proving to be invasive cancers.

In traditional mammography screening, all breast tissue is captured in a single image, whereas breast tomosynthesis is three-dimensional and works according to the same principle as what is known as tomography. More...
In breast tomosynthesis, several low-dose X-ray images of the breast are taken from different angles, which are reconstructed by a computer to show thin layers of the breast. More and improved image information and less overlapping tissue structures increase the chance of detecting tumors. Additionally, the radiation dose can be lowered in certain circumstances.

The extensive screening study conducted by the Swedish researchers used only the 3D method and confirms that breast tomosynthesis is superior to today’s mammography screening in the detection of cancer tumors. In the near future, parts of the image review in connection with breast tomosynthesis could be automated by using computers, although this is likely to take time due to the lack of appropriate ready-to-use and tested software.

“With breast tomosynthesis, 34% more cancer tumors were detected compared to the current standard mammography screening. At the same time, we were able to reduce the compression of the breast during examination, something that may encourage more women to participate in screening,” said Sophia Zackrisson, associate professor at Lund University and radiologist at Skåne University Hospital. “There is a need to improve screening for many women, and breast tomosynthesis is clearly the most appropriate method to transition to in breast cancer screening. Breast tomosynthesis will be introduced, it’s just a question of when and to what extent.”

Related Links:
Lund University
Skåne University Hospital


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Pediatric Mask
Respire SOFT
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.